Friday, 8 June 2018

Budging Stoock

Cipla rises nearly 3% as company to market Eli Lilly#39;s diabetes drugCipla rises nearly 3% as company to market Eli Lilly#39;s diabetes drug Under this agreement, Lilly├ó€™s BASAGLAR that is manufactured by Lilly will be marketed and distributed in India by Cipla.
https://ift.tt/2s01YoW
from Moneycontrol Buzzing Stocks https://ift.tt/2Lv4lY6
via EMMKAY

No comments:

Post a Comment